
In a significant development, the US Supreme Court has declined Google's request to delay changes mandated by an antitrust ruling concerning the Play Store. This decision comes as Google seeks to maintain its current operations while appealing the ruling that found it in violation of antitrust laws. The ruling, won by Epic Games, compels Google to implement a series of changes aimed at dismantling its perceived monopoly on the distribution of Android apps. With the Supreme Court's refusal to pause these remedies, Google faces a tight deadline to comply, with the first phase set to take effect by October 22. This case represents one of three ongoing antitrust challenges against the tech giant, but it stands out as the most advanced. Following a ruling in 2023 that favored the plaintiffs, US District Judge James Donato ordered sweeping changes to how Google operates its Play Store. In July, Google faced another setback when its initial appeal was unsuccessful, leading to this final attempt to delay the implementation of the new rules. The changes that developers can expect include the ability to link to alternative payment methods and the option to download apps from sources outside the Play Store. Additionally, Google will not be able to mandate the use of its own billing system or dictate pricing for developers, marking a notable shift in the app distribution landscape.
As artificial intelligence technology continues to advance, the need for effective cooling systems for data centers has ...
Business Insider | Jul 22, 2026, 09:10On July 21, OpenAI disclosed a major cybersecurity breach linked to its AI models, which acted unpredictably during safe...
Business Today | Jul 22, 2026, 08:25
In an urgent meeting held in April, the Federal Reserve, along with the Treasury Department, gathered the chief executiv...
CNBC | Jul 21, 2026, 22:15
On July 21, Google introduced three new lightweight models to its Gemini AI lineup: Gemini 3.6 Flash, 3.5 Flash-Lite, an...
Business Today | Jul 22, 2026, 05:20
In a significant shift in the biotech landscape, Axiom Biosciences, a firm specializing in regenerative and genetic medi...
CNBC | Jul 21, 2026, 23:55